Literature DB >> 9606613

Urinary incontinence in the elderly. Causes and treatment options.

S Z Nasr1, J G Ouslander.   

Abstract

Urinary incontinence is a prevalent and distressing condition that affects > 30% of elderly individuals. A wide variety of treatment modalities is available, and can be effective in reducing or eliminating the symptoms and adverse consequences of urinary incontinence. Pharmacological therapy is an important component of the successful management of this condition, but the agents currently used do not act selectively on the lower urinary tract. Adverse effects of drug treatment are common, and are especially problematic in the elderly. A careful assessment of the type of urinary incontinence and the institution of a rational management programme are the keys to improvement or even cure in patients with this condition.

Entities:  

Mesh:

Year:  1998        PMID: 9606613     DOI: 10.2165/00002512-199812050-00002

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  45 in total

1.  The pathophysiology of urinary incontinence among institutionalized elderly persons.

Authors:  N M Resnick; S V Yalla; E Laurino
Journal:  N Engl J Med       Date:  1989-01-05       Impact factor: 91.245

Review 2.  Prevalence and incidence of urinary incontinence in community-dwelling populations.

Authors:  A R Herzog; N H Fultz
Journal:  J Am Geriatr Soc       Date:  1990-03       Impact factor: 5.562

3.  Treatment of benign prostatic hyperplasia.

Authors:  P C Walsh
Journal:  N Engl J Med       Date:  1996-08-22       Impact factor: 91.245

4.  Impact of urinary incontinence on health-care costs.

Authors:  T W Hu
Journal:  J Am Geriatr Soc       Date:  1990-03       Impact factor: 5.562

5.  Incontinence in elderly cared for by family.

Authors:  L S Noelker
Journal:  Gerontologist       Date:  1987-04

6.  Prospective study comparing hyoscyamine, doxazosin, and combination therapy for the treatment of urgency and frequency in women.

Authors:  S Serels; M Stein
Journal:  Neurourol Urodyn       Date:  1998       Impact factor: 2.696

7.  Oral desmopressin as a new treatment modality for primary nocturnal enuresis in adolescents and adults: a double-blind, randomized, multicenter study. Dutch Enuresis Study Group.

Authors:  R A Janknegt; H M Zweers; K P Delaere; A G Kloet; S G Khoe; H J Arendsen
Journal:  J Urol       Date:  1997-02       Impact factor: 7.450

8.  Urinary incontinence in elderly nursing home patients.

Authors:  J G Ouslander; R L Kane; I B Abrass
Journal:  JAMA       Date:  1982-09-10       Impact factor: 56.272

9.  A double-blind crossover trial of baclofen--a new treatment for the unstable bladder syndrome.

Authors:  M C Taylor; C P Bates
Journal:  Br J Urol       Date:  1979-12

Review 10.  Urinary incontinence associated with dementia.

Authors:  J Skelly; A J Flint
Journal:  J Am Geriatr Soc       Date:  1995-03       Impact factor: 5.562

View more
  2 in total

Review 1.  Extended-release oxybutynin.

Authors:  A M Comer; K L Goa
Journal:  Drugs Aging       Date:  2000-02       Impact factor: 3.923

2.  Cost Effectiveness of Controlled-Release Oxybutynin Compared with Immediate-Release Oxybutynin and Tolterodine in the Treatment of Overactive Bladder in the UK, France and Austria.

Authors:  Julian F Guest; Dele Abegunde; Francis J Ruiz
Journal:  Clin Drug Investig       Date:  2004       Impact factor: 2.859

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.